This site is intended for healthcare professionals
  • Home
  • /
  • Clinical trials
  • /
  • Uncategorised Disease
  • /
  • A phase II, open-label, multicenter, randomized st...
Clinical trial

A phase II, open-label, multicenter, randomized study to investigate the efficacy and safety of MPDL3280a (Anti-PD-L1 Antibody) compared with docetaxel in patients with Non-Small Cell Lung Cancer after platinum failure

Read time: 1 mins
Last updated:8th Aug 2013
Register for free access to this exclusive healthcare learning resource


Why sign up with Medthority?

Develop your knowledge with our disease and condition focused Learning Zones

Access content from credible sources, including expert-led commentary, videos, podcasts, and webinars as well as clinical trials, treatment information and guidelines 

Personalised dashboard providing updates and recommendations for content within your areas of interest